SCHEMBL4767965

SCHEMBL4767965

C[Si](C)(C)CCOCn1ccc2c(Oc3c(F)cc(NC(=O)C(F)(F)F)cc3F)ccnc21

nearest known ligand 0.37

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
MET P08581 16/20 0.37
AXL P30530 2/20 0.34
HCRTR2 O43614 1/20 0.33
BRAF P15056 1/20 0.33
RIPK2 O43353 1/20 0.33
EGFR P00533 1/20 0.32
IGF1R P08069 1/20 0.32
KIT P10721 1/20 0.32
SRC P12931 1/20 0.32
KDR P35968 1/20 0.32
MST1R Q04912 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29821745 0.91 MET (0.37) METAXLHCRTR2EGFRIGF1R
SCHEMBL20588392 0.86 MET (0.37) METAXLEGFRIGF1RKIT
SCHEMBL29821807 0.85 KIT (0.41) METAXLKIT
SCHEMBL20588989 0.85 MET (0.34) METAXLBRAFEGFRIGF1R
SCHEMBL20587650 0.85 ATM (0.38) AXL
SCHEMBL4767990 0.84 ROCK2 (0.35) METAXLBRAFRIPK2
SCHEMBL20588922 0.84 KMT2A (0.44)
SCHEMBL20588188 0.84 MET (0.34) METAXLBRAFEGFRIGF1R
SCHEMBL20588225 0.84 MET (0.34) METAXLBRAFEGFRIGF1R
SCHEMBL20659574 0.84 MAP4K1 (0.37) METAXLBRAFEGFRIGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1751153-B1 HETARYLOXY-SUBSTITUTED PHENYLAMINO PYRIMIDINES AS RHO KINASE INHIBITORS BAYER HEALTHCARE AG (DE) 2008-12-03 EP disclosed
EP-1751153-A1 HETARYLOXY-SUBSTITUTED PHENYLAMINO PYRIMIDINES AS RHO KINASE INHIBITORS Bayer HealthCare AG (DE) 2007-02-14 EP disclosed
WO-2005097790-A1 HETARYLOXY-SUBSTITUTED PHENYLAMINO PYRIMIDINES AS RHO KINASE INHIBITORS BAYER HEALTHCARE AG (DE) 2005-10-20 WO disclosed